title: [The clinico-histochemical validation of the differential use of calcium antagonists in gastroduodenal ulcers].
abstract: A therapeutic effect of selective calcium antagonists is more evident in older patients with peptide ulcer and under differentiated administration: verapamil is indicated for mediogastric ulcer, nifedipine and diltiazem are better for pyloroantral and duodenal ulcer defect. Responses in ulcer patients may be due to the drugs positive action on ulcer-induced disturbances in the neuromediator processes running in gastroduodenal mucosa.
authors.forename: N A
authors.initials: NA
authors.lastname: Birg
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004341:Drug Evaluation; D004525:Efferent Pathways / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005753:Gastric Mucosa / Q000187:drug effects / Q000294:innervation / Q000378:metabolism / Q000473:pathology; D006651:Histocytochemistry; D006801:Humans; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D012008:Recurrence
chemical_list: D002121:Calcium Channel Blockers
vernacular_title: Kliniko-gistokhimicheskie obosnovaniia differentsial'nogo primeneniia antagonistov kal'tsiia pri gastroduodenal'nykh iazvakh.